GLYCODESIGN

GlycoDesign is a biopharmaceutical company, engages in the discovery and development of proprietary drugs for the treatment or prevention of cardiovascular and chronic inflammatory diseases, as well as cancer. It focuses on two anti-thrombotic drug candidates, GH9001 and ATH, as well as in the development of glycotherapeutics for the potential treatment of chronic inflammation and cancer.

#SimilarOrganizations #Financial #Website #More

GLYCODESIGN

Industry:
Biotechnology Pharmaceutical

Founded:
1993-01-01

Address:
Toronto, Ontario, Canada

Country:
Canada

Website Url:
http://www.glycodesign.com

Total Employee:
11+

Status:
Closed

Contact:
(416) 593-6027


Similar Organizations

not_available_image

Proacta Therapeutics

Proacta Therapeutics is a biopharmaceutical company, engages in the discovery and development of oncology drugs.

Acquisitions List

Date Company Article Price
1999-11-08 Vascular Therapeutics Vascular Therapeutics acquired by GlycoDesign N/A

Official Site Inspections

http://www.glycodesign.com

  • Host name: a904c694c05102f30.awsglobalaccelerator.com
  • IP address: 76.223.54.146
  • Location: Seattle United States
  • Latitude: 47.54
  • Longitude: -122.3032
  • Metro Code: 819
  • Timezone: America/Los_Angeles
  • Postal: 98108

Loading ...

More informations about "GlycoDesign" on Search Engine